NewsBenzinga모건스탠리, CMS 에너지 투자의견 ‘동등비중’ 유지·목표주가 77달러로 하향 모건스탠리, CMS 에너지 투자의견 ‘동등비중’ 유지·목표주가 77달러로 하향 Benzinga 2026.09.18 13:28 (GMT+0) Open on Benzinga Other news Keefe, Bruyette & Woods Maintains Outperform on Everest Group, Lowers Price Target to $407 Keefe, Bruyette & Woods Maintains Market Perform on Cincinnati Financial, Lowers Price Target to $171 UBS Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $18 Full Transcript: Cerence Q3 2026 Earnings Call Transcript: PAR Technology Q2 2026 Earnings Conference Call Keefe, Bruyette & Woods Maintains Outperform on Chubb, Lowers Price Target to $387
Keefe, Bruyette & Woods Maintains Market Perform on Cincinnati Financial, Lowers Price Target to $171
